Reducing the length of diagnostic pathways can increase the number treatment options available and enable better patient experiences. Here, Neal Navani, PhD, of University College London Hospitals NHS Foundation Trust, London, UK, discusses exciting data in this area from the British Thoracic Oncology Group (BTOG) Annual Conference 2018, held in Dublin, Ireland.
Rapid diagnostic pathways for lung cancer
